Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the quarter ended March 31, 2025, and provided a business update.Read More
Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates
By PR Newswire
